 |
|
|
| |
JNJ-64530440, a Novel Capsid Assembly Modulator: Single- and Multiple-Ascending Dose Safety, Tolerability and Pharmacokinetics in Healthy Volunteers
|
| |
| |
Reported by Jules Levin
EASL The International Liver Congress, Vienna, Austria, April 10-14, 2019
Thomas N. Kakuda1, Jeysen Z. Yogaratnam1, Christopher Westland1, Edward J. Gane2, Christian Schwabe3, Megha Patel1, Willem Talloen4, Oliver Lenz4, Pieter van Remoortere5
1Janssen BioPharma Inc., South San Francisco, CA, USA; 2New Zealand Liver Transplant Unit, University of Auckland, Auckland, New Zealand; 3Auckland Clinical Studies, Auckland, New Zealand; 4Janssen Pharmaceutica NV, Beerse, Belgium; 5Janssen Pharmaceuticals, Titusville, NJ, USA.
|
| |
|
|
|
|
|
